International Association of
Therapeutic Drug Monitoring and Clinical Toxicology
Fostering education, research and practice in TDM and CT

Young Scientist Awards

Presented for Best Young Scientist Oral and Best Young Scientist Poster Presentations

The awards shall be presented for the best Young Scientist oral and best Young Scientist poster presentations at the IATDMCT Congress.

  • One award will be presented for the best Young Scientist oral presentation.
  • One award will be presented for the best Young Scientist poster presentation.

Terms of Reference

  • The Young Scientist (YS) awards will be presented by the President at the Closing Ceremony of each Congress.
  • The two winners will be awarded the sum of $ 750 each.
  • These prizes are reserved, according to the regulations of the Young Scientists Committee (YSC), to IATDMCT members aged 40 years or younger.
  • The YS member must be the first author of the oral / poster presentation abstract.
  • The YS member will have to be registered and present at the Congress.
  • The YS member will have to apply for the awards when submitting the abstract.
  • Members of the YSC are not eligible to be considered for the awards.
  • The jury will be made up of at least three members of the YSC.
  • If a member of the YSC is a co-author of the abstract, it will be considered for the award, however, the YSC co-author will be excluded from assessing this entry.
  • In case of equal top marks for a given award, the jury will deliberate and then a vote will be held to select the recipient of the award by "simple majority".
  • The same person should not receive both of these awards, unless duly justified by exceptional achievements in the jury’s opinion.
  • If, in the opinion of the Young Scientist Committee, no suitable candidate is available the Awards shall not be presented.

Pre-Congress Abstract Evaluation Guidelines

  • Prior to the Congress the YSC will select, from the submitted abstracts, a minimum of 10 Oral abstracts and a minimum of 10 Poster abstracts to be assessed for the awards at the Congress.
  • Each abstract will be evaluated by at least 3 members of the YSC. If available, abstract assessment by the scientific sub-committees will be considered by the YSC particularly in the areas of scientific novelty and significance / impact.
  • The abstracts will be assessed based on the following criteria:
    • Clarity
      (Mark 1 to 2, with 1 being the highest)
    • Significance / impact in TDM or CT
      (Mark 1 to 3, with 1 being the highest)
    • Scientific content / Technical challenge
      (Mark 1 to 5, with 1 being the highest)
    • Scientific novelty
      (Mark 1 to 2, with 1 being the highest)

Congress Awards Evaluation Guidelines

Following the pre-Congress evaluation the selected oral and poster presentations will be assessed by 3 members of the YSC jury independently during the Congress. The YSC jury may also consider inviting the session chair(s) to assist with evaluation, especially if abstracts are being presented in parallel sessions.

The Oral and Poster presentation will be assessed based on the following criteria:

  • Originality, scientific or clinical importance
    (Mark 1 to 5, with 1 being the highest)
  • Degree of scientific/technical content and challenge
    (Mark 1 to 5, with 1 being the highest)
  • Knowledge of subject area and ability to respond to questions
    (Mark 1 to 5, with 1 being the highest)
  • Quality of the poster, its structure and visual presentation
    or
    Quality of slides, its structure and delivery of oral presentation
    (Mark 1 to 5, with 1 being the highest)

2018 Recipient - Best Oral Presentation

A.cannaert
Annelies Cannaert, Belgium

Sponsored by

IATDMCT


IATDMCT Logo Blue 150x150

A novel activity-based concept to screen biological matrices for the presence of (synthetic) opioids

Past Recipients

  • 2017 Natalia Riva, Argentina
  • 2015 Fabienne Thomas, France
  • 2013 Jessica Welter, Germany
  • 2011 Andrea E Schwaninger, Germany
  • 2009 Flora Musuamba Tshinanu, Belgium

2018 Recipient - Best Poster

J.versmissen
Jorie Versmissen, The Netherlands

Sponsored by

IATDMCT


IATDMCT Logo Blue 150x150

Drug non-adherence, defined by undetectable drug levels, as cause of hypertensive urgency or emergency at the emergency department.

Past Recipients

  • 2017 Lea Wagmann, Germany
  • 2015 Lucie Pouche, France
  • 2013 Violetter MG Gijsen, Netherlands/Canada
  • 2011 Fabien Lamoureux, France
  • 2009 Isabelle Delattre

contactus273x169

Contact Us
IATDMCT Awards
Young Scientist Committee